Ultragenyx Pharmaceutical (RARE) Current Assets (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) posted Current Assets of $606 million for Q2 2026, down 15.8% from $719.79 million a year earlier and down 7.8% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical's Current Assets came in at $951 million, up 16.4% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of -6.0% (FY2020 to FY2025).
- In prior years, Ultragenyx Pharmaceutical's Current Assets was $817 million in FY2024 (+11.6%), $732.18 million in FY2023 (-17.2%), $883.9 million in FY2022 (+3.2%) and $856.6 million in FY2021 (-33.9%).
- The Q2 2026 figure stands as the lowest quarterly Current Assets since Q1 2024.
- On a year-over-year basis, Current Assets increased in four of the last eight quarters, with growth averaging 1.5%.
- The strongest year-over-year quarter for Current Assets in the past five years was Q2 2024, with growth of 37.4%; the weakest was Q3 2023, with a decline of 40.8%.
- According to Business Quant data, Current Assets for the three prior quarters was $657 million (Q1 2026), $951 million (Q4 2025) and $643.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.51 Bn | -292.70 Mn | 180.00 Mn | 606.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 606.00 Mn |
| Mar 31, 2026 | 657.00 Mn |
| Dec 31, 2025 | 951.00 Mn |
| Sep 30, 2025 | 643.21 Mn |
| Jun 30, 2025 | 719.79 Mn |
| Mar 31, 2025 | 699.16 Mn |
| Dec 31, 2024 | 817.00 Mn |
| Sep 30, 2024 | 799.61 Mn |
| Jun 30, 2024 | 964.64 Mn |
| Mar 31, 2024 | 595.97 Mn |
| Dec 31, 2023 | 732.18 Mn |
| Sep 30, 2023 | 599.19 Mn |
| Jun 30, 2023 | 702.14 Mn |
| Mar 31, 2023 | 766.34 Mn |
| Dec 31, 2022 | 883.90 Mn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 678.54 Mn |
| Mar 31, 2022 | 707.52 Mn |
| Dec 31, 2021 | 856.60 Mn |
| Sep 30, 2021 | 846.88 Mn |
API Access
Ultragenyx Pharmaceutical Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();